| P50 | author | Viola Calabrò | Q56855177 |
| | Raffaele A. Calogero | Q41241289 |
| | Raffaele Ronca | Q42682812 |
| | Maria Vivo | Q47288303 |
| | Marco Lo Iacono | Q56855173 |
| P2093 | author name string | Girolama La Mantia | |
| | Alessandra Pollice | |
| | Vittorio Nasti | |
| P2860 | cites work | Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas | Q22010990 |
| | The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein | Q24291005 |
| | HEC binds to the seventh regulatory subunit of the 26 S proteasome and modulates the proteolysis of mitotic cyclins | Q24311923 |
| | KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2 | Q24318405 |
| | The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes | Q24319734 |
| | ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways | Q24321528 |
| | p16INK4A and p19ARF act in overlapping pathways in cellular immortalization | Q60584728 |
| | The 19S Regulatory Complex of the Proteasome Functions Independently of Proteolysis in Nucleotide Excision Repair | Q63383896 |
| | Recognition of misfolding proteins by PA700, the regulatory subcomplex of the 26 S proteasome | Q73462939 |
| | A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator | Q24338540 |
| | p53-independent functions of the p19(ARF) tumor suppressor | Q24600863 |
| | Induction of the Tat-binding protein 1 gene accompanies the disabling of oncogenic erbB receptor tyrosine kinases | Q24651825 |
| | p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes | Q24791745 |
| | The INK4a/ARF network in tumour suppression | Q28190064 |
| | Oligomerization of the human ARF tumor suppressor and its response to oxidative stress | Q28208861 |
| | Association of p14ARF with the p120E4F transcriptional repressor enhances cell cycle inhibition | Q28215807 |
| | The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 | Q28266637 |
| | Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex | Q28582161 |
| | Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization | Q29614701 |
| | Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF | Q29619663 |
| | The 26S proteasome: a molecular machine designed for controlled proteolysis | Q29619692 |
| | HBV X protein targets HIV Tat-binding protein 1. | Q30664574 |
| | The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome | Q33292204 |
| | The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. | Q33889383 |
| | A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal | Q33958676 |
| | E1A signaling to p53 involves the p19(ARF) tumor suppressor | Q35206764 |
| | p19ARF targets certain E2F species for degradation. | Q35260543 |
| | Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer | Q35477427 |
| | Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. | Q35919276 |
| | Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2 | Q36174385 |
| | Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF. | Q39695864 |
| | Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing | Q40666241 |
| | Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors | Q40746150 |
| | The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. | Q40767774 |
| | Suppression of Ras-mediated NIH3T3 transformation by p19ARF does not involve alterations of cell growth properties | Q40955001 |
| | Transcription. Proteasome parts at gene promoters | Q43966331 |
| | Recruitment of a 19S proteasome subcomplex to an activated promoter | Q43966343 |
| | Human p14(Arf): an exquisite sensor of morphological changes and of short-lived perturbations in cell cycle and in nucleolar function | Q44165071 |
| | The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16INK4a/MTS1 gene. | Q52528311 |
| | Tumor surveillance via the ARF-p53 pathway. | Q53430438 |
| | p14ARF links the tumour suppressors RB and p53. | Q55067966 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6345-6353 | |
| P577 | publication date | 2003-12-09 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Functional and physical interaction of the human ARF tumor suppressor with Tat-binding protein-1. | |
| P478 | volume | 279 | |